
About Care Ratings Limited
Data last updated:
Care Ratings Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the credit rating agencies segment of the financial services sector. It was incorporated on 21 April 1993 and has been in existence for over 33 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN L67190MH1993PLC071691. Its GSTIN is 27AAACC4587F1ZM (Maharashtra). The company holds 12 GST registrations, of which 11 are active. It is a listed company as per MCA records. Its shares are listed on BSE: 534804 and NSE: CARERATING.
The company has an authorised share capital of ₹35 Cr and a paid-up capital of ₹30.06 Cr. It was formerly known as Credit Analysis and Research Limited. It is led by directors including Mehul Harshadray Pandya (Managing Director) and Gurumoorthy Mahalingam.
Its last annual general meeting (AGM) was held on 10 July 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Godrej Coliseum 4th Flr Somaiya Hosp Road Off E Exp Highway Sion E, Mumbai, Maharashtra, India – 400022.
As per the latest consolidated financials for FY 2025-26, the company reported a revenue of ₹473.07 Cr, a growth of 17.6% compared to the previous year. For the same year it recorded a net profit of ₹171.17 Cr (net margin 36.2%) and EBITDA of ₹197.4 Cr (EBITDA margin 41.7%). The net worth stands at ₹932.45 Cr (up 15.6% YoY). Total assets are valued at ₹985.41 Cr (up 15% YoY).
The company has about 571 employees on its provident fund (EPFO) records. Its group structure includes 2 subsidiaries.
The company is associated with 4 brands: Amul Dairy, Peoplewiz Consulting, CARE Ratings and CareEdge. As per MCA filings, the company has satisfied charges of ₹1.53 Cr on record. Court records list 135 cases involving the company, including 18 filed by the company and 117 filed against it; 42 cases are pending. The company has 49 deals on record (39 market trades, 7 secondary share transfers, 3 funding rounds), with disclosed funding of ₹25.93 Cr; the latest was in September 2026. Its 3 peer companies in the BFSI industry (Credit Rating and Information Services), with the same principal business activity (other financial activities) are compared by revenue, 1 larger and 2 smaller; the largest is Icra Limited with revenue of ₹575.43 Cr. The company has 2 MSME Form 1 returns on record between 2019 and 2020, listing 7 overdue payments to 4 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website careratings.com.
Company details
Name history
Care Ratings has undergone 2 name changes throughout its history. The company was previously known as Care Ratings Limited, and Credit Analysis And Research Limited. The current legal name is Care Ratings Limited.
| Company Name | Status |
|---|---|
| Care Ratings Limited | Current |
| Credit Analysis And Research Limited | Previous |
CIN history
Care Ratings has one previous CIN (Corporate Identification Number): U67190MH1993PLC071691. The current CIN is L67190MH1993PLC071691, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L67190MH1993PLC071691 | Current |
| U67190MH1993PLC071691 | Previous |
Contact details
Care Ratings Limited's registered office is in Mumbai, Maharashtra. Its website is careratings.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressGodrej Coliseum 4th Flr Somaiya Hosp Road Off E Exp Highway Sion E, Mumbai, Maharashtra, India – 400022
- IndustryFinancial Services, Credit Rating Agencies
To see the full contact details of Care Ratings Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Care Ratings operates multiple associated brands including Amul Dairy, Peoplewiz Consulting, and CARE Ratings. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Cooperative organization for milk production, animal health, and dairy services in India. | amuldairy.com | |
| Delivers comprehensive solutions in talent management, employee branding, and workforce analytics. | peoplewizconsulting.com | |
| Provider of independent credit ratings and assessments for businesses | careratings.com | |
| Provider of credit ratings, analytics, consulting, and sustainability services | careedge.in |
Business activity
The main business activity of Care Ratings is financial and insurance service. In detail, this covers other financial activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| K | Financial and insurance Service | K8 | Other financial activities |
To see the full business activity and turnover split of Care Ratings Limited, buy the company report.
Financials of Care Ratings Limited
FY 2025-26 filings availableCare Ratings Limited reported revenue of ₹473.07 Cr (up 17.6% YoY) for FY 2025-26.
Financial Highlights
FY 2025-26 · ConsolidatedRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 473 | 402 | 332 | 279 | 248 | 248 | 244 |
| Revenue growth | +17.6% | +21.3% | +18.9% | +12.7% | -0.3% | +2.0% | - |
| EBITDA | 197 | 155 | 112 | 99.34 | 79.60 | 95.77 | 81.32 |
| EBITDA margin | +41.7% | +38.6% | +33.8% | +35.6% | +32.1% | +38.6% | +33.4% |
| Profit before tax | 235 | 192 | 147 | 126 | 98.62 | 119 | 104 |
| Net profit | 171 | 137 | 101 | 83.53 | 75.10 | 89.51 | 82.37 |
| Net profit margin | +36.2% | +34.1% | +30.3% | +29.9% | +30.3% | +36.0% | +33.8% |
| EPS (₹) | 56.97 | 45.85 | 33.67 | 28.12 | 25.33 | 30.38 | 27.96 |
| Balance sheet | |||||||
| Total assets | 985 | 857 | 760 | 709 | 673 | 611 | 553 |
| Net worth | 932 | 806 | 717 | 672 | 648 | 589 | 533 |
| Total debt | 26.18 | 23.77 | 19.55 | 17.48 | 8.91 | 7.23 | 0.00 |
| Cash & bank | 129 | 97.00 | 58.38 | 56.45 | 82.16 | 290 | 115 |
| Net working capital | 543 | 598 | 598 | 546 | 516 | 291 | 124 |
| Cash flow | |||||||
| Cash from operations | 148 | 123 | 90.88 | 82.24 | 68.00 | 86.17 | 67.40 |
| Cash from investing | (94.45) | (58.43) | (39.07) | 12.88 | (27.32) | (37.72) | 26.73 |
| Cash from financing | (59.33) | (54.00) | (62.96) | (63.33) | (35.14) | (43.36) | (107) |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 112 | 131 | 112 | 136 | 93.91 | 110 | 96.38 | 117 |
| Revenue growth (YoY) | +18.9% | +19.2% | +16.3% | +16.2% | +19.0% | - | - | - |
| Other income | 14.80 | 15.71 | 12.99 | 12.58 | 13.70 | 15.17 | 11.85 | 11.86 |
| EBITDA | 34.63 | 60.75 | 40.34 | 68.41 | 27.74 | 47.37 | 30.43 | 55.72 |
| EBITDA margin | +31.0% | +46.5% | +36.0% | +50.2% | +29.5% | +43.2% | +31.6% | +47.5% |
| Depreciation | 3.86 | 3.83 | 3.69 | 3.46 | 3.40 | 3.06 | 3.00 | 2.85 |
| Interest | 0.60 | 0.63 | 0.65 | 0.61 | 0.60 | 0.60 | 0.56 | 0.49 |
| Profit before tax | 44.97 | 72.00 | 48.99 | 76.92 | 37.44 | 58.88 | 38.72 | 64.24 |
| Tax | 11.98 | 18.56 | 12.46 | 19.70 | 10.94 | 15.52 | 10.35 | 17.36 |
| Net profit | 32.99 | 53.44 | 36.53 | 57.22 | 26.50 | 43.36 | 28.37 | 46.88 |
| EPS (₹) | 10.70 | 17.51 | 11.91 | 18.81 | 8.56 | 14.17 | 9.30 | 15.36 |
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 388 | 337 | 283 | 249 | 219 | 220 | 219 |
| Revenue growth | +15.2% | +18.9% | +13.8% | +13.5% | -0.2% | +0.3% | - |
| EBITDA | 187 | 155 | 124 | 110 | 86.00 | 88.27 | 76.54 |
| EBITDA margin | +48.3% | +46.1% | +43.8% | +44.1% | +39.2% | +40.2% | +34.9% |
| Profit before tax | 232 | 197 | 162 | 138 | 107 | 113 | 100 |
| Net profit | 174 | 148 | 119 | 104 | 84.46 | 85.83 | 80.48 |
| Net profit margin | +45.0% | +44.0% | +42.2% | +41.7% | +38.5% | +39.1% | +36.7% |
| EPS (₹) | 58.04 | 49.44 | 40.01 | 34.95 | 28.49 | 29.13 | 27.32 |
| Balance sheet | |||||||
| Total assets | 1,013 | 886 | 787 | 718 | 665 | 600 | 546 |
| Net worth | 984 | 858 | 759 | 695 | 650 | 583 | 532 |
| Total debt | 15.57 | 15.71 | 16.69 | 13.65 | 4.22 | 6.49 | 0.00 |
| Cash & bank | 67.82 | 26.56 | 30.50 | 42.76 | 71.27 | 269 | 101 |
| Net working capital | 473 | 526 | 555 | 515 | 490 | 259 | 103 |
| Cash flow | |||||||
| Cash from operations | 142 | 121 | 107 | 94.51 | 63.54 | 82.47 | 65.69 |
| Cash from investing | (98.31) | (71.91) | (59.61) | (2.22) | (22.87) | (37.80) | 25.93 |
| Cash from financing | (53.07) | (52.93) | (59.96) | (61.74) | (34.59) | (42.71) | (106) |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 88.15 | 108 | 90.24 | 114 | 75.64 | 91.24 | 78.59 | 102 |
| Revenue growth (YoY) | +16.5% | +17.9% | +14.8% | +12.6% | +15.8% | - | - | - |
| Other income | 15.63 | 15.39 | 13.16 | 12.54 | 14.74 | 15.51 | 11.43 | 11.76 |
| Total expenses | 56.06 | 49.68 | 53.00 | 49.30 | 48.50 | 45.49 | 48.29 | 44.60 |
| EBITDA | 32.09 | 57.90 | 37.24 | 64.97 | 27.14 | 45.75 | 30.30 | 56.91 |
| EBITDA margin | +36.4% | +53.8% | +41.3% | +56.9% | +35.9% | +50.1% | +38.6% | +56.1% |
| Depreciation | 2.33 | 2.33 | 2.30 | 2.30 | 2.09 | 1.95 | 2.01 | 1.98 |
| Interest | 0.37 | 0.38 | 0.39 | 0.40 | 0.41 | 0.38 | 0.39 | 0.40 |
| Profit before tax | 45.02 | 70.58 | 47.71 | 74.81 | 39.38 | 58.93 | 39.33 | 66.29 |
| Tax | 11.15 | 17.20 | 11.65 | 18.98 | 10.26 | 14.04 | 9.86 | 16.66 |
Financial Statements
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 112 | 131 | 112 | 136 | 93.91 | 110 | 96.38 | 117 |
| Revenue growth (YoY) | +18.9% | +19.2% | +16.3% | +16.2% | +19.0% | - | - | - |
| Other income | 14.80 | 15.71 | 12.99 | 12.58 | 13.70 | 15.17 | 11.85 | 11.86 |
| EBITDA | 34.63 | 60.75 | 40.34 | 68.41 | 27.74 | 47.37 | 30.43 | 55.72 |
| EBITDA margin | +31.0% | +46.5% | +36.0% | +50.2% | +29.5% | +43.2% | +31.6% | +47.5% |
| Depreciation | 3.86 | 3.83 | 3.69 | 3.46 | 3.40 | 3.06 | 3.00 | 2.85 |
| Interest | 0.60 | 0.63 | 0.65 | 0.61 | 0.60 | 0.60 | 0.56 | 0.49 |
| Profit before tax | 44.97 | 72.00 | 48.99 | 76.92 | 37.44 | 58.88 | 38.72 | 64.24 |
| Tax | 11.98 | 18.56 | 12.46 | 19.70 | 10.94 | 15.52 | 10.35 | 17.36 |
| Net profit | 32.99 | 53.44 | 36.53 | 57.22 | 26.50 | 43.36 | 28.37 | 46.88 |
| EPS (₹) | 10.70 | 17.51 | 11.91 | 18.81 | 8.56 | 14.17 | 9.30 | 15.36 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 473 | 402 | 332 | 279 | 248 | 248 | 244 |
| Revenue growth | +17.6% | +21.3% | +18.9% | +12.7% | -0.3% | +2.0% | - |
| Other income | 54.81 | 50.75 | 46.69 | 37.94 | 27.19 | 31.29 | 31.47 |
| Total expenses | 276 | 247 | 220 | 180 | 168 | 153 | 162 |
| Employee cost | 215 | 189 | 165 | 134 | 126 | 120 | 109 |
| EBITDA | 197 | 155 | 112 | 99.34 | 79.60 | 95.77 | 81.32 |
| EBITDA margin | +41.7% | +38.6% | +33.8% | +35.6% | +32.1% | +38.6% | +33.4% |
| Depreciation | 14.37 | 11.72 | 10.48 | 10.53 | 7.71 | 7.80 | 7.77 |
| Interest | 2.49 | 2.11 | 1.71 | 1.00 | 0.46 | 0.62 | 0.93 |
| Profit before tax | 235 | 192 | 147 | 126 | 98.62 | 119 | 104 |
| Tax | 61.66 | 52.26 | 44.07 | 40.29 | 21.80 | 27.68 | 20.61 |
| Net profit | 171 | 137 | 101 | 83.53 | 75.10 | 89.51 | 82.37 |
| Net profit margin | +36.2% | +34.1% | +30.3% | +29.9% | +30.3% | +36.0% | +33.8% |
| EPS (₹) | 56.97 | 45.85 | 33.67 | 28.12 | 25.33 | 30.38 | 27.96 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 30.05 | 29.93 | 29.85 | 29.70 | 29.65 | 29.46 | 29.46 |
| Reserves & surplus | 902 | 776 | 687 | 643 | 618 | 559 | 480 |
| Shareholders' funds (net worth) | 932 | 806 | 717 | 672 | 648 | 589 | 533 |
| Minority interest | 10.68 | 9.23 | 7.46 | 6.83 | 5.31 | 4.22 | 3.25 |
| Secured loans | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Unsecured loans | 26.18 | 23.77 | 19.55 | 17.48 | 8.91 | 7.23 | 0.00 |
| Total debt | 26.18 | 23.77 | 19.55 | 17.48 | 8.91 | 7.23 | 0.00 |
| Total liabilities | 985 | 857 | 760 | 709 | 673 | 611 | 553 |
| Assets | |||||||
| Gross block | 163 | 157 | 140 | 132 | 115 | 102 | 106 |
| Net block | 122 | 119 | 109 | 107 | 95.62 | 85.07 | 93.11 |
| Capital work in progress | 5.32 | 2.92 | 5.99 | 4.23 | 8.19 | 3.15 | 0.52 |
| Investments | 86.88 | 134 | 43.82 | 43.91 | 44.00 | 240 | 339 |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sundry debtors | 35.04 | 32.09 | 22.49 | 21.51 | 16.64 | 21.36 | 40.89 |
| Cash & bank balances | 129 | 97.00 | 58.38 | 56.45 | 82.16 | 290 | 115 |
| Loans & advances | 493 | 563 | 594 | 525 | 465 | 29.53 | 27.94 |
| Total current assets | 657 | 692 | 675 | 603 | 564 | 341 | 183 |
| Total current liabilities | 113 | 94.53 | 76.26 | 57.02 | 47.96 | 50.15 | 59.82 |
| Net working capital | 543 | 598 | 598 | 546 | 516 | 291 | 124 |
| Total assets | 985 | 857 | 760 | 709 | 673 | 611 | 553 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 48.82 | 38.29 | 49.42 | 17.63 | 12.09 | 6.99 | 19.82 |
| Net cash from operating activities | 148 | 123 | 90.88 | 82.24 | 68.00 | 86.17 | 67.40 |
| Net cash from investing activities | (94.45) | (58.43) | (39.07) | 12.88 | (27.32) | (37.72) | 26.73 |
| Net cash from financing activities | (59.33) | (54.00) | (62.96) | (63.33) | (35.14) | (43.36) | (107) |
| Net change in cash | (6.22) | 10.53 | (11.14) | 31.79 | 5.55 | 5.09 | (12.83) |
| Closing cash | 129 | 97.00 | 58.38 | 56.45 | 82.16 | 290 | 115 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +17.6% | +21.3% | +18.9% | +12.7% | -0.3% | +2.0% | - |
| EBITDA growth | +27.1% | +38.6% | +12.9% | +24.8% | -16.9% | +17.8% | - |
| PBT growth | +22.4% | +31.1% | +16.6% | +27.5% | -16.9% | +14.0% | -48.4% |
| Net income growth | +24.7% | +36.6% | +20.3% | +11.2% | -16.1% | +8.7% | - |
| Revenue CAGR (3Y) | +19.3% | +17.6% | +10.1% | +4.6% | -8.1% | -9.3% | -5.4% |
| EBITDA CAGR (3Y) | +25.7% | +25.0% | +5.4% | +6.9% | -23.0% | -23.1% | -23.6% |
| Profitability & leverage | |||||||
| Net income margin | +36.7% | +34.8% | +30.9% | +30.6% | +31.0% | +36.6% | +34.3% |
| Return on capital employed | +26.1% | +24.3% | +20.4% | +18.5% | +15.5% | +20.6% | +19.0% |
| Return on net worth | +20.0% | +18.4% | +14.8% | +13.0% | +12.4% | +16.2% | +15.4% |
| Debt / equity | 0.03 | 0.03 | 0.03 | 0.02 | 0.01 | 0.01 | 0.00 |
| Long-term debt / equity | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.00 | 0.00 |
| Interest cover | 1.36 | 1.47 | 1.68 | 1.13 | 0.64 | 0.70 | 1.26 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 2.96 | 2.71 | 2.44 | 2.26 | 2.29 | 2.39 | 2.46 |
| Inventory turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debtors turnover | 14.09 | 14.74 | 15.47 | 15.07 | 13.03 | 7.98 | 5.53 |
| EPS (₹) | 56.97 | 45.85 | 33.67 | 28.12 | 25.33 | 30.38 | 27.96 |
| Dividend per share (₹) | 22.00 | 18.00 | 18.00 | 25.00 | 17.00 | 17.00 | 19.50 |
| Book value per share (₹) | 310.29 | 269.37 | 240.23 | 226.33 | 218.41 | 199.86 | 173.02 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 88.15 | 108 | 90.24 | 114 | 75.64 | 91.24 | 78.59 | 102 |
| Revenue growth (YoY) | +16.5% | +17.9% | +14.8% | +12.6% | +15.8% | - | - | - |
| Other income | 15.63 | 15.39 | 13.16 | 12.54 | 14.74 | 15.51 | 11.43 | 11.76 |
| Total expenses | 56.06 | 49.68 | 53.00 | 49.30 | 48.50 | 45.49 | 48.29 | 44.60 |
| EBITDA | 32.09 | 57.90 | 37.24 | 64.97 | 27.14 | 45.75 | 30.30 | 56.91 |
| EBITDA margin | +36.4% | +53.8% | +41.3% | +56.9% | +35.9% | +50.1% | +38.6% | +56.1% |
| Depreciation | 2.33 | 2.33 | 2.30 | 2.30 | 2.09 | 1.95 | 2.01 | 1.98 |
| Interest | 0.37 | 0.38 | 0.39 | 0.40 | 0.41 | 0.38 | 0.39 | 0.40 |
| Profit before tax | 45.02 | 70.58 | 47.71 | 74.81 | 39.38 | 58.93 | 39.33 | 66.29 |
| Tax | 11.15 | 17.20 | 11.65 | 18.98 | 10.26 | 14.04 | 9.86 | 16.66 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 388 | 337 | 283 | 249 | 219 | 220 | 219 |
| Revenue growth | +15.2% | +18.9% | +13.8% | +13.5% | -0.2% | +0.3% | - |
| Other income | 55.68 | 51.39 | 46.96 | 37.10 | 28.36 | 32.12 | 31.34 |
| Total expenses | 200 | 182 | 159 | 139 | 133 | 131 | 143 |
| Employee cost | 163 | 146 | 125 | 104 | 107 | 103 | 96.70 |
| EBITDA | 187 | 155 | 124 | 110 | 86.00 | 88.27 | 76.54 |
| EBITDA margin | +48.3% | +46.1% | +43.8% | +44.1% | +39.2% | +40.2% | +34.9% |
| Depreciation | 9.02 | 7.94 | 7.65 | 8.05 | 6.99 | 7.09 | 6.91 |
| Interest | 1.59 | 1.58 | 1.48 | 0.70 | 0.40 | 0.57 | 0.74 |
| Profit before tax | 232 | 197 | 162 | 138 | 107 | 113 | 100 |
| Tax | 58.08 | 49.02 | 42.44 | 34.34 | 22.51 | 26.90 | 19.75 |
| Net profit | 174 | 148 | 119 | 104 | 84.46 | 85.83 | 80.48 |
| Net profit margin | +45.0% | +44.0% | +42.2% | +41.7% | +38.5% | +39.1% | +36.7% |
| EPS (₹) | 58.04 | 49.44 | 40.01 | 34.95 | 28.49 | 29.13 | 27.32 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 30.05 | 29.93 | 29.85 | 29.70 | 29.65 | 29.46 | 29.46 |
| Reserves & surplus | 954 | 828 | 729 | 665 | 621 | 554 | 479 |
| Shareholders' funds (net worth) | 984 | 858 | 759 | 695 | 650 | 583 | 532 |
| Secured loans | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Unsecured loans | 15.57 | 15.71 | 16.69 | 13.65 | 4.22 | 6.49 | 0.00 |
| Total debt | 15.57 | 15.71 | 16.69 | 13.65 | 4.22 | 6.49 | 0.00 |
| Total liabilities | 1,013 | 886 | 787 | 718 | 665 | 600 | 546 |
| Assets | |||||||
| Gross block | 127 | 128 | 120 | 113 | 99.35 | 91.72 | 94.04 |
| Net block | 91.80 | 92.81 | 92.98 | 90.85 | 81.95 | 76.34 | 82.63 |
| Capital work in progress | 4.89 | 2.92 | 1.47 | 2.86 | 6.52 | 3.74 | 0.34 |
| Investments | 207 | 255 | 129 | 112 | 70.51 | 266 | 359 |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sundry debtors | 25.43 | 22.48 | 14.71 | 15.19 | 13.61 | 16.69 | 36.02 |
| Cash & bank balances | 67.82 | 26.56 | 30.50 | 42.76 | 71.27 | 269 | 101 |
| Loans & advances | 470 | 553 | 568 | 500 | 443 | 14.68 | 17.62 |
| Total current assets | 563 | 602 | 614 | 558 | 528 | 300 | 155 |
| Total current liabilities | 89.95 | 76.34 | 58.33 | 42.74 | 37.31 | 40.96 | 51.34 |
| Net working capital | 473 | 526 | 555 | 515 | 490 | 259 | 103 |
| Total assets | 1,013 | 886 | 787 | 718 | 665 | 600 | 546 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 26.35 | 30.29 | 42.51 | 11.96 | 5.88 | 3.93 | 18.33 |
| Net cash from operating activities | 142 | 121 | 107 | 94.51 | 63.54 | 82.47 | 65.69 |
| Net cash from investing activities | (98.31) | (71.91) | (59.61) | (2.22) | (22.87) | (37.80) | 25.93 |
| Net cash from financing activities | (53.07) | (52.93) | (59.96) | (61.74) | (34.59) | (42.71) | (106) |
| Net change in cash | (9.07) | (3.94) | (12.22) | 30.55 | 6.08 | 1.95 | (14.40) |
| Closing cash | 67.82 | 26.56 | 30.50 | 42.76 | 71.27 | 269 | 101 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +15.2% | +18.9% | +13.8% | +13.5% | -0.2% | +0.3% | - |
| EBITDA growth | +20.8% | +25.1% | +13.0% | +27.7% | -2.6% | +15.3% | - |
| PBT growth | +18.0% | +21.7% | +17.2% | +29.1% | -5.1% | +12.5% | -49.4% |
| Net income growth | +17.8% | +23.9% | +15.1% | +22.9% | -1.6% | +6.7% | - |
| Revenue CAGR (3Y) | +15.9% | +15.4% | +8.8% | +4.3% | -9.7% | -11.9% | -7.9% |
| EBITDA CAGR (3Y) | +19.5% | +21.7% | +12.0% | +12.8% | -20.5% | -25.0% | -25.6% |
| Profitability & leverage | |||||||
| Net income margin | +45.0% | +44.0% | +42.2% | +41.7% | +38.5% | +39.1% | +36.7% |
| Return on capital employed | +24.7% | +23.7% | +21.7% | +20.1% | +17.0% | +19.8% | +18.3% |
| Return on net worth | +18.9% | +18.3% | +16.4% | +15.4% | +13.7% | +15.4% | +14.9% |
| Debt / equity | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.00 |
| Long-term debt / equity | 0.02 | 0.02 | 0.02 | 0.01 | 0.00 | 0.00 | 0.00 |
| Interest cover | 0.89 | 1.07 | 1.27 | 0.69 | 0.51 | 0.70 | 1.06 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 3.04 | 2.71 | 2.43 | 2.35 | 2.30 | 2.36 | 2.47 |
| Inventory turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debtors turnover | 16.19 | 18.11 | 18.93 | 17.28 | 14.47 | 8.33 | 5.51 |
| EPS (₹) | 58.04 | 49.44 | 40.01 | 34.95 | 28.49 | 29.13 | 27.32 |
| Dividend per share (₹) | 22.00 | 18.00 | 18.00 | 25.00 | 17.00 | 17.00 | 19.50 |
| Book value per share (₹) | 327.36 | 286.60 | 254.34 | 233.96 | 219.33 | 197.98 | 172.45 |
To see the full year-wise statements and ratios of Care Ratings Limited, buy the company report.
Board of directors of Care Ratings Limited
Care Ratings has 8 current directors and 31 former directors. Current directors are listed first, with their designation and appointment date.
Peer comparison
Care Ratings Limited is compared with the 3 companies closest to it by revenue in the BFSI industry (Credit Rating and Information Services), with the same principal business activity (other financial activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Icra Limited | ₹575.43 Cr (FY 2025) | 10.0% | New Delhi, Delhi, India | |||
| Care Ratings Limitedthis company | ₹473.07 Cr (FY 2026) | ₹171.17 Cr | 36.2% | 17.6% | 571 | Mumbai, Maharashtra, India |
| India Ratings and Research Private Limited | ₹233.18 Cr (FY 2025) | 10.0% | Mumbai, Maharashtra, India | |||
| NSE Indices Limited | ₹160.39 Cr (FY 2025) | -49.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Care Ratings Limited, buy the company report.
Auditor
Care Ratings Limited is audited by B S R & Co. LLP for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| B S R & Co. LLP | FY 2024 | 101248W/W-100022 |
Shareholding
Shareholding for the quarter ended Sep 2026: promoters hold 0.00%, foreign institutional investors hold 23.40%, domestic institutional investors hold 31.60% and retail and other public shareholders hold 45.00%.
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | |
|---|---|---|---|---|
| Promoters | 0.00% | 0.00% | 0.00% | 0.00% |
| Public | 100.00% | 100.00% | 100.00% | 100.00% |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 07 Jan 2026 | 101224564 | Idbi Bank Limited | ₹11.93 Lakh | Satisfied | |
| 30 Nov 2021 | 100511428 | Hdfc Bank Limited | ₹31.35 Lakh | Satisfied | |
| 30 Nov 2021 | 100511433 | Hdfc Bank Limited | ₹1.1 Cr | Satisfied |
To see the full charge records of Care Ratings Limited, buy the company report.
Total charge records: 3 View all charges
Deals & funding
Care Ratings Limited has 49 deals on record (39 market trades, 7 secondary share transfers, 3 funding rounds), with disclosed funding of ₹25.93 Cr; the latest was in September 2026.
Deals on record (5 of 49)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jul 2022 | Market trade | ₹11.53 Cr | Buyer: Graviton Research Capital LLP Seller: Graviton Research Capital LLP |
| Jul 2021 | Market trade | ₹11.57 Cr | Buyer: Graviton Research Capital LLP Seller: Graviton Research Capital LLP |
| Jun 2021 | Market trade | ₹12.28 Cr | Buyer: XTX Markets LLP Seller: XTX Markets LLP |
| Jun 2021 | Market trade | ₹12.05 Cr | Buyer: XTX Markets LLP Seller: XTX Markets LLP |
| Jun 2021 | Market trade | ₹21.97 Cr | Buyer: XTX Markets LLP , Graviton Research Capital LLP Seller: XTX Markets LLP , Graviton Research Capital LLP |
To see the full deal history of Care Ratings Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Care Ratings Limited has 135 court cases on record: 18 filed by Care Ratings, 117 filed against it. 42 cases are pending and 93 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 113 | 101 | 36 |
| District courts | 11 | 11 | 2 |
| NCLAT | 7 | 2 | 4 |
| Supreme Court | 4 | 3 | 0 |
Cases on record (5 of 135)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, TAMIL NADU | Interim or miscellaneous application | Filed against the company by Catalyst Trusteeship Limited | Pending |
| High Court | Appeal | Filed against the company by M/S Chaturvedi and Shah LLP | Pending |
| High Court | Writ petition | Filed against the company by Itecsys Technologies Pvt Ltd and 1 other | Pending |
| High Court, TAMIL NADU | Court case (OSA(CAD)) | Filed against the company by Chaturvedi and Shah LLP Anirudh Krishnan, Adarsh Subramanian,Sasank Iyer,K.Mohit Kumar,Varun Venkatesan,Rupikaa Srinivasan | Pending |
| High Court, TAMIL NADU | Interim or miscellaneous application | Filed against the company by Chaturvedi and Shah LLP | Pending |
To see the full case history of Care Ratings Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Care Ratings Limited has 2 MSME Form 1 returns on record between 2019 and 2020, listing 7 overdue payments to 4 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (4 of 4)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| an individual supplier | |||
| an individual supplier | |||
| an individual supplier |
To see the full MSME payment records of Care Ratings Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Care Ratings has 2 subsidiary companies. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Care Risk Solutions Private Limited | U74210MH1999PTC118349 | |
| Care Advisory Research and Training Limited | U74999MH2016PLC285575 |
To see the full group structure of Care Ratings Limited, buy the company report.
Employees & EPFO
Care Ratings Limited has a workforce of 571 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.
GST
Care Ratings has 12 GST registrations: 11 active and 1 cancelled or inactive. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACC4587F1ZM | Maharashtra | Active | 01 Jul 2017 |
| 04AAACC4587F1ZU | Chandigarh | Active | 01 Jul 2017 |
| 07AAACC4587F1ZO | Delhi | Active | 01 Jul 2017 |
| 08AAACC4587F1ZM | Rajasthan | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Care Ratings Limited, buy the company report.
Recent activity
Care Ratings Limited has 62 board changes on record since 1993: 36 appointments and 26 cessations. The latest: Bimalkumar Natvarlal Patel was appointed as Additional Director on 12 Nov 2025.
59 earlier events are in the company report.
News
Frequently asked questions
Care Ratings is an active public limited company based in Mumbai, Maharashtra, India. The company works in credit rating agencies, within the financial services industry. It was incorporated on 21 April 1993 (33+ years old) and is registered under CIN L67190MH1993PLC071691. Listed on BSE: 534804 and NSE: CARERATING.
Care Ratings reported revenue of ₹473.07 Cr for FY 2025-26 (up 17.6% YoY) based on consolidated financials.
Care Ratings has 8 current directors:
- Mehul Harshadray Pandya - Managing Director
- Gurumoorthy Mahalingam - Director
- Venkatadri Chandrasekaran - Director
- Sobhag Jain - Director
- Bimalkumar Natvarlal Patel - Additional Director
- Rajiv Bansal - Director
- Indrani Banerjee - Director
- Manoj Chugh - Director
The latest financial statements of Care Ratings on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 10 July 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Care Ratings is 27AAACC4587F1ZM, registered in Maharashtra. The company has 12 GST registrations in all, of which 11 are active and 1 is cancelled or inactive. Other active GSTINs include 04AAACC4587F1ZU (Chandigarh), 07AAACC4587F1ZO (Delhi), 08AAACC4587F1ZM (Rajasthan).
The CIN (Corporate Identification Number) of Care Ratings is L67190MH1993PLC071691. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. Care Ratings is a listed company as per MCA records. Its shares are listed on both BSE (code: 534804) and NSE (symbol: CARERATING).
Care Ratings has 135 court cases on record: 18 filed by the company and 117 filed against it. 42 are pending. Most are in the high courts.
Care Ratings was incorporated on 21 April 1993, making it 33+ years old. It is registered with the Registrar of Companies, Mumbai.
Care Ratings has 49 deals on record (39 market trades, 7 secondary share transfers, 3 funding rounds), with disclosed funding of ₹25.93 Cr; the latest was in September 2026.
The peers of Care Ratings by revenue are Icra Limited, India Ratings and Research Private Limited, NSE Indices Limited, all in the BFSI industry (Credit Rating and Information Services), with the same principal business activity (other financial activities).
Bimalkumar Natvarlal Patel was appointed as Additional Director on 12 Nov 2025. Madasamy Mathisekaran ceased to be Director on 11 Jul 2025. Najib Shah ceased to be Director on 11 Jul 2025. Care Ratings has 62 board changes on record in total.

